MARKET

VALN

VALN

Valneva Se
NASDAQ
9.91
+0.24
+2.43%
Opening 12:08 02/10 EST
OPEN
9.97
PREV CLOSE
9.68
HIGH
10.09
LOW
9.91
VOLUME
2.74K
TURNOVER
--
52 WEEK HIGH
12.25
52 WEEK LOW
5.43
MARKET CAP
851.28M
P/E (TTM)
-13.8330
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VALN last week (0202-0206)?
Weekly Report · 1d ago
Valneva SE Reports 173,877,420 Issued Shares and 189,607,235 Voting Rights
Reuters · 4d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 6d ago
Valneva and Instituto Butantan Launch Pilot Chikungunya Vaccination Campaign in Brazil
TipRanks · 02/03 14:49
Valneva SE and Instituto Butantan Launch Chikungunya Vaccine Pilot in Brazil
Reuters · 02/03 06:00
Valneva SE startet Impfstoff-Partnerschaft mit Instituto Butantan gegen Chikungunya
Reuters · 02/03 06:00
VALNEVA AND INSTITUTO BUTANTAN ANNOUNCE INITIATION OF A PILOT VACCINATION CAMPAIGN IN BRAZIL WITH SINGLE-SHOT CHIKUNGUNYA VACCINE IXCHIQ®
Reuters · 02/03 06:00
Weekly Report: what happened at VALN last week (0126-0130)?
Weekly Report · 02/02 10:35
More
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Webull offers Valneva SE (ADR) stock information, including NASDAQ: VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.